Distinct Populations of Cancer Stem Cells Determine Tumor Growth and Metastatic Activity in Human Pancreatic Cancer

Cell Stem Cell

Volumn 1, Issue 3, 2007, Pages 313-323

  Hermann, Patrick C ^a   Huber, Stephan L ^a   Herrler, Tanja ^a   Aicher, Alexandra ^c   Ellwart, Joachim W ^b   Guba, Markus ^a   Bruns, Christiane J ^a   Heeschen, Christopher ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c GOETHE UNIVERSITY   (Germany)

Author keywords

CELLCYCLE; STEMCELL

Indexed keywords

1,1' [1,4 PHENYLENEBIS(METHYLENE)]BIS(1,4,8,11 TETRAAZACYCLOTETRADECANE); CD33 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; GEMCITABINE; STROMAL CELL DERIVED FACTOR 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CHEMOTHERAPY; CANCER INHIBITION; CANCER INVASION; CANCER STEM CELL; CARCINOGENICITY; CELL MIGRATION; CELL SUBPOPULATION; CONTROLLED STUDY; DEPLETION; DRUG EFFICACY; HUMAN; HUMAN CELL; HUMAN TISSUE; METASTASIS; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PANCREAS CANCER; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH;

ANIMALS; ANTIGENS, CD; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DRUG RESISTANCE, NEOPLASM; GLYCOPROTEINS; HUMANS; MICE; NEOPLASM METASTASIS; NEOPLASTIC STEM CELLS; PANCREATIC NEOPLASMS; PEPTIDES; RECEPTORS, CXCR4;

EID: 34548455927     PISSN: 19345909     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.stem.2007.06.002     Document Type: Article

References (39)

1. Ahlgren J.D. Chemotherapy for pancreatic carcinoma. Cancer 78 (1996) 654-663
2. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., and Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA 100 (2003) 3983-3988
3. Bachelder R.E., Wendt M.A., and Mercurio A.M. Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4. Cancer Res. 62 (2002) 7203-7206
4. Barnett S.C., Robertson L., Graham D., Allan D., and Rampling R. Oligodendrocyte-type-2 astrocyte (O-2A) progenitor cells transformed with c-myc and H-ras form high-grade glioma after stereotactic injection into the rat brain. Carcinogenesis 19 (1998) 1529-1537
5. Bruns C.J., Harbison M.T., Kuniyasu H., Eue I., and Fidler I.J. In vivo selection and characterization of metastatic variants from human pancreatic adenocarcinoma by using orthotopic implantation in nude mice. Neoplasia 1 (1999) 50-62
6. Burger J.A., and Kipps T.J. CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood 107 (2006) 1761-1767
7. Clarke M.F., Dick J.E., Dirks P.B., Eaves C.J., Jamieson C.H., Jones D.L., Visvader J., Weissman I.L., and Wahl G.M. Cancer stem cells-perspectives on current status and future directions: AACR workshop on cancer stem cells. Cancer Res. 66 (2006) 9339-9344
8. Dalerba P., Cho R.W., and Clarke M.F. Cancer stem cells: models and concepts. Annu. Rev. Med. 58 (2007) 267-284
9. Denham M., Huynh T., Dottori M., Allen G., Trounson A., and Mollard R. Neural stem cells express non-neural markers during embryoid body coculture. Stem Cells 24 (2006) 918-927
10. Dick J.E. Acute myeloid leukemia stem cells. Ann. N Y Acad. Sci. 1044 (2005) 1-5
11. Dontu G., Abdallah W.M., Foley J.M., Jackson K.W., Clarke M.F., Kawamura M.J., and Wicha M.S. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev. 17 (2003) 1253-1270
12. Fargeas C.A., Corbeil D., and Huttner W.B. AC133 antigen, CD133, prominin-1, prominin-2, etc.: prominin family gene products in need of a rational nomenclature. Stem Cells 21 (2003) 506-508
13. He X.C., Yin T., Grindley J.C., Tian Q., Sato T., Tao W.A., Dirisina R., Porter-Westpfahl K.S., Hembree M., Johnson T., et al. PTEN-deficient intestinal stem cells initiate intestinal polyposis. Nat. Genet. 39 (2007) 189-198
14. Jemal A., Tiwari R.C., Murray T., Ghafoor A., Samuels A., Ward E., Feuer E.J., and Thun M.J. Cancer statistics, 2004. CA Cancer J. Clin. 54 (2004) 8-29
15. Jordan C.T., Guzman M.L., and Noble M. Cancer stem cells. N. Engl. J. Med. 355 (2006) 1253-1261
16. Kim C.F., Jackson E.L., Woolfenden A.E., Lawrence S., Babar I., Vogel S., Crowley D., Bronson R.T., and Jacks T. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 121 (2005) 823-835
17. Kucia M., Reca R., Miekus K., Wanzeck J., Wojakowski W., Janowska-Wieczorek A., Ratajczak J., and Ratajczak M.Z. Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis. Stem Cells 23 (2005) 879-894
18. Li C., Heidt D.G., Dalerba P., Burant C.F., Zhang L., Adsay V., Wicha M., Clarke M.F., and Simeone D.M. Identification of pancreatic cancer stem cells. Cancer Res. 67 (2007) 1030-1037
19. Loetscher P., Moser B., and Baggiolini M. Chemokines and their receptors in lymphocyte traffic and HIV infection. Adv. Immunol. 74 (2000) 127-180
20. Matano E., Tagliaferri P., Libroia A., Damiano V., Fabbrocini A., De Lorenzo S., and Bianco A.R. Gemcitabine combined with continuous infusion 5-fluorouracil in advanced and symptomatic pancreatic cancer: a clinical benefit-oriented phase II study. Br. J. Cancer 82 (2000) 1772-1775
21. Moll R. Cytokeratins as markers of differentiation in the diagnosis of epithelial tumors. Subcell. Biochem. 31 (1998) 205-262
22. Muller A., Homey B., Soto H., Ge N., Catron D., Buchanan M.E., McClanahan T., Murphy E., Yuan W., Wagner S.N., et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 410 (2001) 50-56
23. O'Brien C.A., Pollett A., Gallinger S., and Dick J.E. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445 (2007) 106-110
24. Passegue E., Jamieson C.H., Ailles L.E., and Weissman I.L. Normal and leukemic hematopoiesis: are leukemias a stem cell disorder or a reacquisition of stem cell characteristics?. Proc. Natl. Acad. Sci. USA 100 Suppl 1 (2003) 11842-11849
25. Peichev M., Naiyer A.J., Pereira D., Zhu Z., Lane W.J., Williams M., Oz M.C., Hicklin D.J., Witte L., Moore M.A., and Rafii S. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 95 (2000) 952-958
26. Prindull G. Hypothesis: cell plasticity, linking embryonal stem cells to adult stem cell reservoirs and metastatic cancer cells?. Exp. Hematol. 33 (2005) 738-746
27. Ricci-Vitiani L., Lombardi D.G., Pilozzi E., Biffoni M., Todaro M., Peschle C., and De Maria R. Identification and expansion of human colon-cancer-initiating cells. Nature 445 (2007) 111-115
28. Rosenberg L. Treatment of pancreatic cancer. Promises and problems of tamoxifen, somatostatin analogs, and gemcitabine. Int. J. Pancreatol. 22 (1997) 81-93
29. Rothenberg M.L., Abbruzzese J.L., Moore M., Portenoy R.K., Robertson J.M., and Wanebo H.J. A rationale for expanding the endpoints for clinical trials in advanced pancreatic carcinoma. Cancer 78 (1996) 627-632
30. Saur D., Seidler B., Schneider G., Algul H., Beck R., Senekowitsch-Schmidtke R., Schwaiger M., and Schmid R.M. CXCR4 expression increases liver and lung metastasis in a mouse model of pancreatic cancer. Gastroenterology 129 (2005) 1237-1250
31. Schneider G.P., Salcedo R., Dong H.F., Kleinman H.K., Oppenheim J.J., and Howard O.M.Z. Suradista NSC 651016 inhibits the angiogenic activity of CXCL12-stromal cell-derived factor 1{alpha}. Clin. Cancer Res. 8 (2002) 3955-3960
32. Singh S.K., Hawkins C., Clarke I.D., Squire J.A., Bayani J., Hide T., Henkelman R.M., Cusimano M.D., and Dirks P.B. Identification of human brain tumour initiating cells. Nature 432 (2004) 396-401
33. Staller P., Sulitkova J., Lisztwan J., Moch H., Oakeley E.J., and Krek W. Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL. Nature 425 (2003) 307-311
34. Uchida N., Buck D.W., He D., Reitsma M.J., Masek M., Phan T.V., Tsukamoto A.S., Gage F.H., and Weissman I.L. Direct isolation of human central nervous system stem cells. Proc. Natl. Acad. Sci. USA 97 (2000) 14720-14725
35. Warshaw A.L., and Fernandez-del Castillo C. Pancreatic carcinoma. N. Engl. J. Med. 326 (1992) 455-465
36. Yin A.H., Miraglia S., Zanjani E.D., Almeida-Porada G., Ogawa M., Leary A.G., Olweus J., Kearney J., and Buck D.W. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 90 (1997) 5002-5012
37. Zagzag D., Krishnamachary B., Yee H., Okuyama H., Chiriboga L., Ali M.A., Melamed J., and Semenza G.L. Stromal cell-derived factor-1alpha and CXCR4 expression in hemangioblastoma and clear cell-renal cell carcinoma: von Hippel-Lindau loss-of-function induces expression of a ligand and its receptor. Cancer Res. 65 (2005) 6178-6188
38. Zeelenberg I.S., Ruuls-Van Stalle L., and Roos E. The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases. Cancer Res. 63 (2003) 3833-3839
39. Zou Y.R., Kottmann A.H., Kuroda M., Taniuchi I., and Littman D.R. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 393 (1998) 595-599